Filing Details

Accession Number:
0001415889-25-018128
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-24 18:33:12
Reporting Period:
2025-06-23
Filing Date:
2025-06-24
Accepted Time:
2025-06-24 18:33:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1796280 Oric Pharmaceuticals Inc. ORIC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1695028 Dominic Piscitelli C/O Oric Pharmaceuticals, Inc.
240 E. Grand Ave., 2Nd Floor
South San Francisco CA 94080
Chief Financial Officer No No No No
Transaction Summary
Sold: 33,500 shares Avg. Price: $10.49 Total Value: $351,383.60
Number of Shares After Transactions: 68,317 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-06-23 584 $10.00 101,233 No 4 S Direct
Common Stock Disposition 2025-06-23 450 $10.01 100,783 No 4 S Direct
Common Stock Disposition 2025-06-24 32,466 $10.50 68,317 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024.
  2. Represents the weighted average share price of an aggregate total of 32,466 shares sold in the price range of $10.34 to $10.80 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.